Europe Pharmaceutical Manufacturing Market Size & Outlook
Europe pharmaceutical manufacturing market, 2018-2030 (US$M)
Related Markets
Europe pharmaceutical manufacturing market highlights
- The Europe pharmaceutical manufacturing market generated a revenue of USD 173,768.6 million in 2023.
- The market is expected to grow at a CAGR of 8.5% from 2024 to 2030.
- In terms of segment, conventional drugs (small molecules) was the largest revenue generating molecule type in 2023.
- Conventional Drugs (Small Molecules) is the most lucrative molecule type segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 173,768.6 million |
| Market revenue in 2030 | USD 306,734.1 million |
| Growth rate | 8.5% (CAGR from 2023 to 2030) |
| Largest segment | Conventional drugs (small molecules) |
| Fastest growing segment | Conventional Drugs (Small Molecules) |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules) |
| Key market players worldwide | Roche Holding AG ADR, Novartis AG ADR, GlaxoSmithKline, Pfizer Inc, Merck & Co Inc, AstraZeneca PLC, Johnson & Johnson, Sanofi SA, Eli Lilly and Co, AbbVie Inc, Thermo Fisher Scientific Inc, Wuxi AppTec Co Ltd, Samsung BioLogics, FUJIFILM Holdings Corp, Lonza Group Ltd, Catalent Inc, Jubilant Pharmova |
Other key industry trends
- In terms of revenue, Europe region accounted for 34.5% of the global pharmaceutical manufacturing market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 207,213.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Manufacturing Market Scope
Pharmaceutical Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe pharmaceutical manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical manufacturing market will help companies and investors design strategic landscapes.
Conventional drugs (small molecules) was the largest segment with a revenue share of 51.05% in 2023. Horizon Databook has segmented the Europe pharmaceutical manufacturing market based on biologics & biosimilars (large molecules), conventional drugs (small molecules) covering the revenue growth of each sub-segment from 2018 to 2030.
Research-oriented pharmaceutical efforts have emerged as the key asset of the pharmaceutical industry in Europe. This is supplemented by medical advancements because of constant research, production, and innovation in medicines, with more novel drugs being introduced.
Pharmaceutical manufacturing is one of the region's most lucrative sectors, incorporating state-of-the-art technologies. The research-based pharmaceutical sector has the potential to accelerate pharmaceutical production in Europe and ensure its position in this competitive industry.
The R&D in the pharmaceutical sector was considered the major driver in 2020; an estimated USD 41,048 million was invested in R&D in Europe in the same year. As per the EFPIA report of 2021, five countries led pharmaceutical production in 2019.
Reasons to subscribe to Europe pharmaceutical manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe pharmaceutical manufacturing market databook
-
Our clientele includes a mix of pharmaceutical manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe pharmaceutical manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe pharmaceutical manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe pharmaceutical manufacturing market size, by country, 2018-2030 (US$M)
Europe Pharmaceutical Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
